Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. SYBX
stocks logo

SYBX

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2024Q3
FY2024Q4
0.00
-100%
--
--
0.00
-100%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for Synlogic, Inc. (SYBX) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -21.23%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Down
down Image
-21.23%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Synlogic Inc (SYBX.O) is -2.45, compared to its 5-year average forward P/E of -2.00. For a more detailed relative valuation and DCF analysis to assess Synlogic Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-2.00
Current PE
-2.45
Overvalued PE
-1.03
Undervalued PE
-2.97

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
105.95
Current PS
0.00
Overvalued PS
264.39
Undervalued PS
-52.49
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

SYBX News & Events

Events Timeline

Sign Up For More Events
no data image
No Data
Sign Up For More Events

News

[object Object]
Preview
9.5
2024-11-13Newsfilter
Synlogic Reports Third Quarter 2024 Financial Results

  • Financial Performance: Synlogic, Inc. reported no revenue for Q3 2024, down from $0.4 million in Q3 2023, with a net loss of $(0.1) million compared to $(12.1) million the previous year. The company had cash and equivalents of $19.4 million as of September 30, 2024.

  • Strategic Review: The company has engaged Lucid Capital Markets to explore strategic options, including potential mergers or acquisitions, but has not set a timeline for this review or made any decisions regarding future actions.

[object Object]
Preview
7.2
2024-08-08Business Insider
SYBX Stock Earnings: Synlogic Beats EPS for Q2 2024

  • Earnings Report: Synlogic (NASDAQ:SYBX) reported a second-quarter EPS of -15 cents, surpassing the analyst estimate of -51 cents, but did not generate any revenue for the quarter.

  • Automated Coverage: InvestorPlace Earnings utilizes TradeSmith data to provide automated summaries of quarterly earnings reports, highlighting key financial figures and comparisons to analyst expectations.

[object Object]
Preview
-.-
2024-05-24Business Insider
The Summer Stock Exodus: 3 Companies to Ditch Before the Heat Hits
Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Synlogic Inc (SYBX) stock price today?

The current price of SYBX is 1.15 USD — it has decreased -11.54 % in the last trading day.

arrow icon

What is Synlogic Inc (SYBX)'s business?

Synlogic, Inc. is a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases. The Company is focused on rare metabolic disorders, with its lead program, labafenogene marselecobac (SYNB1934), studied in Synpheny-3, a global, pivotal Phase 3 study for patients with phenylketonuria (PKU), and SYNB1353, a potential treatment for homocystinuria (HCU). The Company's early-stage pipeline includes product candidates for enteric hyperoxaluria, gout, and cystinuria, and has been fueled by a reproducible, proprietary approach that creates gastrointestinal (GI)-restricted, oral medicines with new enzymatic pathways designed to consume or produce specific biological targets. The Company designs, develops and manufactures these drug candidates, which are produced by applying genetic engineering to well-characterized probiotics. The Company’s preclinical work includes additional metabolic disease research.

arrow icon

What is the price predicton of SYBX Stock?

Wall Street analysts forecast SYBX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SYBX is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Synlogic Inc (SYBX)'s revenue for the last quarter?

Synlogic Inc revenue for the last quarter amounts to 0.00 USD, decreased % YoY.

arrow icon

What is Synlogic Inc (SYBX)'s earnings per share (EPS) for the last quarter?

Synlogic Inc. EPS for the last quarter amounts to -0.19 USD, increased 1800.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Synlogic Inc (SYBX)'s fundamentals?

The market is revising No Change the revenue expectations for Synlogic, Inc. (SYBX) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -21.23%.
arrow icon

How many employees does Synlogic Inc (SYBX). have?

Synlogic Inc (SYBX) has 1 emplpoyees as of December 05 2025.

arrow icon

What is Synlogic Inc (SYBX) market cap?

Today SYBX has the market capitalization of 13.45M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free